GLP-1s Show No Causal Link To Suicidal Thoughts, Actions In Preliminary FDA Review; Sentinel Scan Is Next

 
• By Sue Sutter
Thumbs up
FDA's investigation into GLP-1s and suicidal thoughts has resulted in a tentative thumbs up for the drug class, with more assessments to come. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet